Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 2
1951 1
1952 1
1953 2
1954 2
1955 6
1956 10
1957 7
1958 7
1959 5
1961 2
1962 1
1963 5
1964 1
1965 1
1966 1
1967 1
1968 1
1969 7
1970 5
1971 2
1972 6
1973 6
1974 6
1975 6
1976 9
1977 6
1978 8
1979 6
1980 10
1981 7
1982 5
1983 12
1984 8
1985 7
1986 6
1987 10
1988 16
1989 21
1990 28
1991 16
1992 23
1993 19
1994 22
1995 18
1996 22
1997 21
1998 20
1999 22
2000 10
2001 20
2002 13
2003 16
2004 16
2005 26
2006 22
2007 15
2008 34
2009 32
2010 32
2011 34
2012 49
2013 55
2014 56
2015 65
2016 67
2017 65
2018 68
2019 51
2020 68
2021 89
2022 88
2023 75
2024 28
2025 1

Text availability

Article attribute

Article type

Publication date

Search Results

1,391 results

Results by year

Filters applied: . Clear all
Page 1
Systematic Functional Annotation of Somatic Mutations in Cancer.
Ng PK, Li J, Jeong KJ, Shao S, Chen H, Tsang YH, Sengupta S, Wang Z, Bhavana VH, Tran R, Soewito S, Minussi DC, Moreno D, Kong K, Dogruluk T, Lu H, Gao J, Tokheim C, Zhou DC, Johnson AM, Zeng J, Ip CKM, Ju Z, Wester M, Yu S, Li Y, Vellano CP, Schultz N, Karchin R, Ding L, Lu Y, Cheung LWT, Chen K, Shaw KR, Meric-Bernstam F, Scott KL, Yi S, Sahni N, Liang H, Mills GB. Ng PK, et al. Among authors: johnson am. Cancer Cell. 2018 Mar 12;33(3):450-462.e10. doi: 10.1016/j.ccell.2018.01.021. Cancer Cell. 2018. PMID: 29533785 Free PMC article.
The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium.
Johnson AM, Barsky M, Ahmed W, Zullow S, Galati J, Jairath V, Narula N, Peerani F, Click BH, Coburn ES, Dang TT, Gold S, Agrawal M, Garg R, Aggarwal M, Mohammad D, Halloran B, Kochhar GS, Todorowski H, Ud Din NM, Izanec J, Teeple A, Gasink C, Muser E, Ding Z, Swaminath A, Lakhani K, Hogan D, Datta S, Ungaro RC, Boland BS, Bohm M, Fischer M, Sagi S, Afzali A, Ullman T, Lawlor G, Baumgart DC, Chang S, Hudesman D, Lukin D, Scherl EJ, Colombel JF, Sands BE, Siegel CA, Regueiro M, Sandborn WJ, Bruining D, Kane S, Loftus EV Jr, Dulai PS. Johnson AM, et al. Am J Gastroenterol. 2023 Feb 1;118(2):317-328. doi: 10.14309/ajg.0000000000002047. Epub 2022 Sep 30. Am J Gastroenterol. 2023. PMID: 36191274
The innate immune response in tauopathies.
Johnson AM, Lukens JR. Johnson AM, et al. Eur J Immunol. 2023 Jun;53(6):e2250266. doi: 10.1002/eji.202250266. Epub 2023 May 4. Eur J Immunol. 2023. PMID: 36932726 Free PMC article. Review.
The Regulation of Nucleic Acid Vaccine Responses by the Microbiome.
Johnson AMF, Hager K, Alameh MG, Van P, Potchen N, Mayer-Blackwell K, Fiore-Gartland A, Minot S, Lin PJC, Tam YK, Weissman D, Kublin JG. Johnson AMF, et al. J Immunol. 2023 Dec 1;211(11):1680-1692. doi: 10.4049/jimmunol.2300196. J Immunol. 2023. PMID: 37850965 Free PMC article.
Update on Immunotherapy Cardiotoxicity: Checkpoint Inhibitors, CAR T, and Beyond.
Patel M, Hudson O, Han J, Kondapalli L, Arora G, Hawi R, Andrikopoulou E, Estes C, Johnson AM, Lenneman C. Patel M, et al. Among authors: johnson am. Curr Treat Options Oncol. 2023 Nov;24(11):1489-1503. doi: 10.1007/s11864-023-01130-y. Epub 2023 Aug 25. Curr Treat Options Oncol. 2023. PMID: 37624557 Review.
Suicidality in Rural College Students: An Integrative Review.
Johnson AM, Smith DL. Johnson AM, et al. J Psychosoc Nurs Ment Health Serv. 2022 Sep;60(9):15-23. doi: 10.3928/02793695-20220325-02. Epub 2022 Apr 13. J Psychosoc Nurs Ment Health Serv. 2022. PMID: 35412874 Review.
ALK: a tyrosine kinase target for cancer therapy.
Holla VR, Elamin YY, Bailey AM, Johnson AM, Litzenburger BC, Khotskaya YB, Sanchez NS, Zeng J, Shufean MA, Shaw KR, Mendelsohn J, Mills GB, Meric-Bernstam F, Simon GR. Holla VR, et al. Among authors: johnson am. Cold Spring Harb Mol Case Stud. 2017 Jan;3(1):a001115. doi: 10.1101/mcs.a001115. Cold Spring Harb Mol Case Stud. 2017. PMID: 28050598 Free PMC article. Review.
RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study.
Nelson BE, Roszik J, Ahmed J, Barretto CMN, Nardo M, Campbell E, Johnson AM, Piha-Paul SA, Oliva ICG, Weathers SP, Cabanillas M, Javle M, Meric-Bernstam F, Subbiah V. Nelson BE, et al. Among authors: johnson am. Mol Cancer. 2024 Mar 26;23(1):64. doi: 10.1186/s12943-024-01982-4. Mol Cancer. 2024. PMID: 38532456 Free PMC article.
1,391 results